Patent ID: 6875843

Claim:
A method of delaying the onset of Type I diabetes in a diabetes-susceptible mammal comprising the step of administering to the mammal an effective amount of a gonadotropin-releasing hormone antagonist selected from the group consisting of Acetyl-β-2-Naphthyl-D-Ala-D-p-Chloro-Phe-β-3-Pyridyl-D-Ala-Ser-Nε-Nicotinoyl-Lys-Nε-Nicotinoyl-D-Lys-Leu-Nε-Isopropyl-Lys-Pro-D-Ala-NH 2 , Abarelix, Nal-Glu, Deslorelin, Histrelin, Nafarelin, Ganirelix, Cetrorelix or the acetate salt thereof, Azaline B, and Degarelix or the acetate salt thereof, wherein said administration results in said mammal having a delayed onset of diabetes.